Health Services Research

Seminars in Radiation Oncology

Volumn 18, Issue 3, 2008, Pages 152-160

  Litwin, Mark S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH INSURANCE; HEALTH SERVICES RESEARCH; MEDICAL CARE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PRODUCTIVITY;

HEALTH CARE COSTS; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES RESEARCH; HUMANS; QUALITY OF HEALTH CARE; QUALITY OF LIFE;

EID: 44149128410     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semradonc.2008.01.002     Document Type: Article

References (135)

1. Andersen R.M., and Davidson P.L. Improving access to care in America. In: Anderson R.M., Rice T.H., and Kominski G.F. (Eds). Changing the U.S. Health Care System. (ed 2) (2001), Jossey-Bass, San Francisco, CA
2. Andersen R.M. Revisiting the behavioral model and access to medical care: Does it matter?. J Health Soc Behav 36 (1995) 1-10
3. Aday L.A., and Andersen R.M. Equity of access to medical care: A conceptual and empirical overview. Med Care 19 (1981) 4-27
4. Griffiths V., Ahmed-Jushuf I., and Cassell J.A. Understanding access to genitourinary medicine services. Int J STD AIDS 15 (2004) 587-589
5. Fitzpatrick P., Corcoran N., and Fitzpatrick J.M. Prostate cancer: How aware is the public?. Br J Urol 82 (1998) 43-48
6. Kelley E., Moy E., Stryer D., et al. The national healthcare quality and disparities reports: An overview. Med Care 43 suppl (2005) I3-I8
7. Kelley E., Moy E., and Dayton E. Health care quality and disparities: lessons from the first national reports. Med Care 43 suppl (2005) I1-I2
8. Rajfer J., Aronson W.J., Bush P.A., et al. Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med 326 (1992) 90-94
9. Lee T.H. My insurance company won't pay for my prescription for Viagra without a letter from my doctor saying that I have been evaluated. As far as I know, I am the only one who can tell whether I have impotence. What does the insurance company want?. Harv Heart Lett 9 (1999) 7
10. Walsh D.C., Connor E., Tracey L.V., et al. Posthospital convalescence and return to work. Health Aff (Millwood) 8 (1989) 76-90
11. Luz J., and Green M.S. Sickness absenteeism from work-A critical review of the literature. Public Health Rev 25 (1997) 89-122
12. Stewart W.F., Ricci J.A., Chee E., et al. Lost productive work time costs from health conditions in the United States: Results from the American Productivity Audit. J Occup Environ Med 45 (2003) 1234-1246
13. Munoz E., Mallett E., Gerold T., et al. Access and quality of care for urology patients under diagnostic related group reimbursement. J Urol 139 (1988) 1256-1259
14. Kahn K.L., Rubenstein L.V., Draper D., et al. The effects of the DRG-based prospective payment system on quality of care for hospitalized Medicare patients. An introduction to the series. JAMA 17264 (1990) 1953-1955
15. Munoz E., Goldstein J., Lory M.H., et al. The DRG hospital payment system, surgical readmissions and cost containment. Am Surg 56 (1990) 683-687
16. Munoz E., Boiardo R., Mulloy K., et al. Economies of scale, physician volume for urology patients, and DRG prospective hospital payment system. Urology 36 (1990) 471-476
17. Munoz E., Mulloy K., Goldstein J., et al. Physicians' patient load per DRG, the consumption of hospital resources, and the incentives of the DRG prospective payment system. Acad Med 65 (1990) 533-538
18. Munoz E., Barrau L., Goldstein J., et al. DRG prospective, "all payor systems," financial risk, and hospital cost in pulmonary medicine non CC stratified DRGs. Chest 94 (1988) 855-861
19. Shepard D.S., and Thompson M.S. First principles of cost-effectiveness analysis in health. Public Health Rep 94 (1979) 535-543
20. Chandhoke P.S., and DeAntoni E. Cost-effectiveness analysis: application to endourology. J Endourol 12 (1998) 485-491
21. Henriksson P., and Edhag O. Cost-effectiveness comparison of estrogen therapy and orchidectomy in patients with prostatic cancer. Int J Technol Assess Health Care 3 (1987) 523-529
22. Manca A., Sculpher M.J., Ward K., et al. A cost-utility analysis of tension-free vaginal tape versus colposuspension for primary urodynamic stress incontinence. BJOG 110 (2003) 255-262
23. Smith T.J., Hillner B.E., and Desch C.E. Efficacy and cost-effectiveness of cancer treatment: Rational allocation of resources based on decision analysis. J Natl Cancer Inst 1585 (1993) 1460-1474
24. Saigal C.S., Gornbein J., Nease R., et al. Predictors of utilities for health states in early stage prostate cancer. J Urol 166 (2001) 942-946
25. Saigal C.S., Gornbein J., Reid K., et al. Stability of time trade-off utilities for health states associated with the treatment of prostate cancer. Qual Life Res 11 (2002) 405-414
26. Nease Jr. R.F., and Owens D.K. A method for estimating the cost-effectiveness of incorporating patient preferences into practice guidelines. Med Decis Making 14 (1994) 382-392
27. Albertsen P.C., Nease Jr. R.F., and Potosky A.L. Assessment of patient preferences among men with prostate cancer. J Urol 159 (1998) 158-163
28. Bennett C.L., Greenfield S., Aronow H., et al. Patterns of care related to age of men with prostate cancer. Cancer 1567 (1991) 2633-2641
29. Joudi F.N., Smith B.J., O'Donnell M.A., et al. Contemporary management of superficial bladder cancer in the United States: A pattern of care analysis. Urology 62 (2003) 1083-1088
30. Bird V.G., Fallon B., and Winfield H.N. Practice patterns in the treatment of large renal stones. J Endourol 17 (2003) 355-363
31. O'Leary M.P., Gee W.F., Holtgrewe H.L., et al. 1999 American Urological Association Gallup Survey: Changes in physician practice patterns, treatment of incontinence and bladder cancer, and impact of managed care. J Urol 164 (2000) 1311-1316
32. Fallon E., Ercole B., Lee C., et al. Contemporary management of ureteropelvic junction obstruction: practice patterns in Minnesota. J Endourol 19 (2005) 41-44
33. Wennberg J.E., et al. Practice variations and health care reform: Connecting the dots. Health Aff (Millwood) Suppl Web Exclusive:VAR140-144 (2004)
34. Weinstein J.N., Bronner K.K., Morgan T.S., et al. Trends and geographic variations in major surgery for degenerative diseases of the hip, knee, and spine. Health Aff (Millwood) Suppl Web Exclusive VAR81-89 (2004)
35. Fisher E.S., Wennberg D.E., Stukel T.A., et al. The implications of regional variations in Medicare spending. Part 1: The content, quality, and accessibility of care. Ann Intern Med 18138 (2003) 273-287
36. Fisher E.S., Wennberg D.E., Stukel T.A., et al. The implications of regional variations in Medicare spending. Part 2: Health outcomes and satisfaction with care. Ann Intern Med 18138 (2003) 288-298
37. Kramolowsky E.V., Wood N.L., Rollins K.L., et al. The role of the physician in effecting change in hospital charge for radical prostatectomy. J Am Coll Surg 180 (1995) 513-518
38. Kramolowsky E.V., Wood N.L., Rollins K.L., et al. Impact of physician awareness on hospital charges for radical retropubic prostatectomy. J Urol 154 (1995) 139-142
39. Sage W.M., Kessler R., Sommers L.S., et al. Physician-generated cost containment in transurethral prostatectomy. J Urol 140 (1988) 311-315
40. Cuckow P.M. Cost of urology: Financial audit in a clinical department. BMJ 26305 (1992) 743-746
41. Cuckow P.M. Costs can and must be a component of surgical audit. Ann R Coll Surg Engl 74 (1992) 406-410 discussion 410-411
42. Forrest J.B., Ritchie Jr. W.P., Hudson M., et al. Cost containment through cost awareness: A strategy that failed. Surgery 90 (1981) 154-158
43. Carter G.M., and Melnick G.A. How Services and Costs Vary by Day of Stay for Medicare Hospital Stays (1990), The RAND Corporation, Santa Monica, CA
44. Haffer S.C., and Bowen S.E. Measuring and improving health outcomes in Medicare: The Medicare HOS program. Health Care Financ Rev 25 (2004) 1-3
45. Holtgrewe H.L. Managed care and its impact on American urology. Urology 51 suppl (1998) 31-35
46. Holtgrewe H.L. The economics of urologic practice in the twenty-first century. Urol Clin North Am 25 (1998) 1-13
47. Greenwald H.P. HMO membership, copayment, and initiation of care for cancer: A study of working adults. Am J Public Health 77 (1987) 461-466
48. Greenwald H.P., and Henke C.J. HMO membership, treatment, and mortality risk among prostatic cancer patients. Am J Public Health 82 (1992) 1099-1104
49. Litwin M.S., Saigal C.S., Yano E.M., et al. Urologic diseases in America Project: Analytical methods and principal findings. J Urol 173 (2005) 933-937
50. Williams R.D. Urologic Diseases in America project. J Urol 173 (2005) 679
51. Iezzoni L.I., Ash A.S., Shwartz M., et al. Judging hospitals by severity-adjusted mortality rates: The influence of the severity-adjustment method. Am J Public Health 86 (1996) 1379-1387
52. Iezzoni L.I. An introduction to risk adjustment. Am J Med Qual 11 (1996) S8-S11
53. Charlson M.E., Pompei P., Ales K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40 (1987) 373-383
54. Greenfield S., Apolone G., McNeil B.J., et al. The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement Comorbidity and outcomes after hip replacement. Med Care 31 (1993) 141-154
55. Kaplan M.H., and Feinstein A.R. The importance of classifying initial co-morbidity in evaluation the outcome of diabetes mellitus. J Chronic Dis 27 (1974) 387-404
56. Greenfield S., Sullivan L., Dukes K.A., et al. Development and testing of a new measure of case mix for use in office practice. Med Care 3 suppl (1995) AS47-AS55
57. Crabtree H.L., Gray C.S., Hildreth A.J., et al. The Comorbidity Symptom Scale: A combined disease inventory and assessment of symptom severity. J Am Geriatr Soc 48 (2000) 1674-1678
58. Di Gangi Herms A.M., Pinggera G.M., De Jonge P., et al. Assessing health care needs and clinical outcome with urological case complexity: A study using INTERMED. Psychosomatics 44 (2003) 196-203
59. Litwin M.S., Greenfield S., Elkin E.P., et al. Assessment of prognosis with the total illness burden index for prostate cancer: Aiding clinicians in treatment choice. Cancer 1109 (2007) 1777-1783
60. Albertsen P.C., Fryback D.G., Storer B.E., et al. The impact of co-morbidity on life expectancy among men with localized prostate cancer. J Urol 156 (1996) 127-132
61. Bodenheimer T. High and rising health care costs. Part 1: Seeking an explanation. Ann Intern Med 17142 (2005) 847-854
62. Corrigan K., and Ryan R.H. New reimbursement models reward clinical excellence. Healthc Financ Manage 58 (2004) 88-92
63. Spencer B.A., Steinberg M., Malin J., et al. Quality-of-care indicators for early-stage prostate cancer. J Clin Oncol 21 (2003) 1928-1936
64. Litwin M.S., Steinberg M., Malin J.L., et al. Prostate Cancer Patient Outcomes and Choice of Providers: Development of an Infrastructure for Quality Assessment (2000), The RAND Corporation, Santa Monica, CA
65. In: Lohr K.N. (Ed). Medicare: A Strategy for Quality Assurance (1990), National Academy Press, Washington, DC
66. Lohr K.N., Donaldson M.S., and Harris-Wehling J. Medicare: A strategy for quality assurance, V: Quality of care in a changing health care environment. QRB Qual Rev Bull 18 (1992) 120-126
67. Donabedian A. Evaluating the quality of medical care. Milbank Mem Fund Q 44 suppl (1966) 166-206
68. Brook R.H., McGlynn E.A., and Shekelle P.G. Defining and measuring quality of care: A perspective from US researchers. Int J Qual Health Care 12 (2000) 281-295
69. Brook R.H., McGlynn E.A., and Cleary P.D. Quality of health care. Part 2: Measuring quality of care. N Engl J Med 335 (1996) 966-970
70. Brook R.H., Kamberg C.J., Lohr K.N., et al. Quality of ambulatory care. Epidemiology and comparison by insurance status and income. Med Care 28 (1990) 392-433
71. Nuttall M., van der Meulen J., Phillips N., et al. A systematic review and critique of the literature relating hospital or surgeon volume to health outcomes for 3 urological cancer procedures. J Urol 172 (2004) 2145-2152
72. Vitale M.A., Arons R.R., Hyman J.E., et al. The contribution of hospital volume, payer status, and other factors on the surgical outcomes of scoliosis patients: A review of 3,606 cases in the State of California. J Pediatr Orthop 25 (2005) 393-399
73. Dibra A., Kastrati A., Schuhlen H., et al. The relationship between hospital or operator volume and outcomes of coronary patients undergoing percutaneous coronary interventions. Z Kardiol 94 (2005) 231-238
74. Killeen S.D., O'Sullivan M.J., Coffey J.C., et al. Provider volume and outcomes for oncological procedures. Br J Surg 92 (2005) 389-402
75. Lyman S., Jones E.C., Bach P.B., et al. The association between hospital volume and total shoulder arthroplasty outcomes. Clin Orthop Relat Res 432 (2005) 132-137
76. Lee K.T., Chang W.T., Huang M.C., et al. Influence of surgeon volume on clinical and economic outcomes of laparoscopic cholecystectomy. Dig Surg 21 (2004) 406-412
77. Katz J.N., Barrett J., Mahomed N.N., et al. Association between hospital and surgeon procedure volume and the outcomes of total knee replacement. J Bone Joint Surg Am 86A (2004) 1909-1916
78. Joshi A.V., and Miller L.A. Hospital procedure volume and outcomes. Ann Intern Med 140 (2004) 1061-1062
79. Begg C.B., Riedel E.R., Bach P.B., et al. Variations in morbidity after radical prostatectomy. N Engl J Med 346 (2002) 1138-1144
80. Hu J.C., Gold K.F., Pashos C.L., et al. Role of surgeon volume in radical prostatectomy outcomes. J Clin Oncol 21 (2003) 401-405
81. Ellison L.M., Heaney J.A., and Birkmeyer J.D. The effect of hospital volume on mortality and resource use after radical prostatectomy. J Urol 163 (2000) 867-869
82. Lu-Yao G.L., Potosky A.L., Albertsen P.C., et al. Follow-up prostate cancer treatments after radical prostatectomy: A population-based study. J Natl Cancer Inst 88 (1996) 166-173
83. Patel A., Dorey F., Franklin J., et al. Recurrence patterns after radical retropubic prostatectomy: Clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen. J Urol 158 (1997) 1441-1445
84. D'Amico A.V., Moul J., Carroll P.R., et al. Surrogate end point for prostate cancer specific mortality in patients with nonmetastatic hormone refractory prostate cancer. J Urol 173 (2005) 1572-1576
85. Schatzkin A., Freedman L.S., Dorgan J., et al. Surrogate end points in cancer research: A critique. Cancer Epidemiol Biomarkers Prev 5 (1996) 947-953
86. Guyatt G.H., Naylor C.D., Juniper E., et al. Users' guides to the medical literature. XII. How to use articles about health-related quality of life. Evidence-Based Medicine Working Group. JAMA 16277 (1997) 1232-1237
87. Guyatt G.H., Bombardier C., and Tugwell P.X. Measuring disease-specific quality of life in clinical trials. CMAJ 134 (1986) 889-895
88. Cella D.F., and Bonomi A.E. Measuring quality of life: 1995 update. Oncology (Huntingt) 9 suppl (1995) 47-60
89. Strasser S., Aharony L., and Greenberger D. The patient satisfaction process: Moving toward a comprehensive model. Med Care Rev 50 (1993) 219-248
90. Cleary P.D., and McNeil B.J. Patient satisfaction as an indicator of quality care. Inquiry 25 (1988) 25-36
91. Hayward R.A., McMahon Jr. L.F., and Bernard A.M. Evaluating the care of general medicine inpatients: How good is implicit review?. Ann Intern Med 1118 (1993) 550-556
92. Aharony L., and Strasser S. Patient satisfaction: What we know about and what we still need to explore. Med Care Rev 50 (1993) 49-79
93. Williams G., Pazdur R., and Temple R. Assessing tumor-related signs and symptoms to support cancer drug approval. J Biopharm Stat 14 (2004) 5-21
94. Patrick D.L., and Erickson P. Assessing health-related quality of life for clinical decision-making. In: Walker S.R., and Rosser R.M. (Eds). Quality of Life Assessment: Key Issues in the 1990's (1993), Kluwer Academic Publishers, Dordrecht 11-64
95. WHO. Constitution of the World Health Organization, Basic Documents (1948), WHO, Geneva
96. Fossa S.D. Quality of life after palliative radiotherapy in patients with hormone-resistant prostate cancer: Single institution experience. Br J Urol 74 (1994) 345-351
97. Litwin M.S. Measuring health related quality of life in men with prostate cancer. J Urol 152 (1994) 1882-1887
98. Tulsky D.S. An introduction to test theory. Oncology (Huntingt) 4 (1990) 43-48
99. Testa M.A., and Simonson D.C. Assessment of quality-of-life outcomes. N Engl J Med 28334 (1996) 835-840
100. McSweeny A.J., and Creer T.L. Health-related quality-of-life assessment in medical care. Dis Mon 41 (1995) 1-71
101. Aaronson N.K. Methodologic issues in assessing the quality of life of cancer patients. Cancer 67 suppl (1991) 844-850
102. Deyo R.A., Diehr P., and Patrick D.L. Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation. Control Clin Trials 12 suppl (1991) 142S-158S
103. Adler N.E., Epel E.S., Castellazzo G., et al. Relationship of subjective and objective social status with psychological and physiological functioning: Preliminary data in healthy white women. Health Psychol 19 (2000) 586-592
104. Nelson E.C., Landgraf J.M., Hays R.D., et al. The functional status of patients. How can it be measured in physicians' offices?. Med Care 28 (1990) 1111-1126
105. Finlay W.M., and Lyons E. Methodological issues in interviewing and using self-report questionnaires with people with mental retardation. Psychol Assess 13 (2001) 319-335
106. Fossa S.D., Aaronson N.K., Newling D., et al. Quality of life and treatment of hormone resistant metastatic prostatic cancer. The EORTC Genito-Urinary Group. Eur J Cancer 26 (1990) 1133-1136
107. Litwin M.S., Lubeck D.P., Henning J.M., et al. Differences in urologist and patient assessments of health related quality of life in men with prostate cancer: Results of the CaPSURE database. J Urol 159 (1998) 1988-1992
108. Slevin M.L., Plant H., Lynch D., et al. Who should measure quality of life, the doctor or the patient?. Br J Cancer 57 (1988) 109-112
109. Fossa S.D., Moynihan C., and Serbouti S. Patients' and doctors' perception of long-term morbidity in patients with testicular cancer clinical stage I. A descriptive pilot study. (see comments). Support Care Cancer 4 (1996) 118-128
110. Lampic C., von Essen L., Peterson V.W., et al. Anxiety and depression in hospitalized patients with cancer: agreement in patient-staff dyads. Cancer Nurs 19 (1996) 419-428
111. Sneeuw K.C., Aaronson N.K., Sprangers M.A., et al. Value of caregiver ratings in evaluating the quality of life of patients with cancer. J Clin Oncol 15 (1997) 1206-1217
112. Sprangers M.A., and Aaronson N.K. The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: A review. J Clin Epidemiol 45 (1992) 743-760
113. Kornblith A.B., Herr H.W., Ofman U.S., et al. Quality of life of patients with prostate cancer and their spouses: The value of a data base in clinical care. Cancer 73 (1994) 2791-2802
114. Testa M.A. Parallel perspectives on quality of life during antihypertensive therapy: Impact of responder, survey environment, and questionnaire structure. J Cardiovasc Pharmacol 21 suppl 2 (1993) S18-S25
115. Patrick D.L., and Deyo R.A. Generic and disease-specific measures in assessing health status and quality of life. Med Care 27 suppl (1989) S217-S232
116. Fossa S.D., Woehre H., Kurth K.H., et al. Influence of urological morbidity on quality of life in patients with prostate cancer. Eur Urol 31 suppl (1997) 3-8
117. McDowell I., and Ewell C. Measuring health: A guide to rating scales and questionnaires (1987), Oxford University Press, New York, NY
118. Ware J.E., Kosinski M., and Keller S.K. SF-36 Physical and Mental Health Summary Scales: A User's Manual (1994), The Health Institute, New England Medical Center, Boston, MA
119. Ware Jr. J.E., and Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30 (1992) 473-483
120. Gandek B., Ware Jr. J.E., Aaronson N.K., et al. Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: Results from the IQOLA Project.International Quality of Life Assessment. J Clin Epidemiol 51 (1998) 1149-1158
121. Kaplan R.M., Bush J.W., and Berry C.C. Health status: Types of validity and the index of well-being. Health Serv Res 11 (1976) 478-507
122. Kaplan R.M., Ganiats T.G., Sieber W.J., et al. The Quality of Well-Being Scale: Critical similarities and differences with SF-36. Int J Qual Health Care 10 (1998) 509-520
123. Kaplan R.M., Sieber W.J., and Ganiats T.G. The quality of well-being scale: comparison of the interviewer-administered version with a self-administered questionnaire. Psychol Health 12 (1997) 783-791
124. Kaplan R.M., and Bush J.W. Health-related quality of life measurement for evaluation research and policy analysis. Health Psychol 1 (1982) 61-80
125. Kaplan R.M., and Anderson J.P. A general health policy model: Update and applications. Health Serv Res 23 (1988) 203-235
126. Anderson J.P., Kaplan R.M., Berry C.C., et al. Interday reliability of function assessment for a health status measure. The Quality of Well-Being scale. Med Care 27 (1989) 1076-1083
127. Bergner M., Bobbitt R.A., Carter W.B., et al. The Sickness Impact Profile: Development and final revision of a health status measure. Med Care 19 (1981) 787-805
128. Bergner M., Bobbitt R.A., Pollard W.E., et al. The sickness impact profile: Validation of a health status measure. Med Care 14 (1976) 57-67
129. Hunt S.M., McEwen J., and McKenna S.P. Measuring health status: A new tool for clinicians and epidemiologists. J R Coll Gen Pract 35 (1985) 185-188
130. McDowell I.W., Martini C.J., and Waugh W. A method for self-assessment of disability before and after hip replacement operations. Br Med J 2 (1978) 857-859
131. Martini C.J., and McDowell I. Health status: Patient and physician judgments. Health Serv Res 11 (1976) 508-515
132. Ware Jr. J., Kosinski M., and Keller S.D. A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Med Care 34 (1996) 220-233
133. Ware J.E., Kosinski M., and Keller S.D. SF-12: How to Score the SF-12 Physical and Mental Health Summary Scales. (ed 1) (1995), The Health Institute, New England Medical Center, Boston, MA
134. Gandek B., Ware J.E., Aaronson N.K., et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: Results from the IQOLA Project.International Quality of Life Assessment. J Clin Epidemiol 51 (1998) 1171-1178
135. Tannock I.F. Management of breast and prostate cancer: How does quality of life enter the equation?. Oncology (Huntingt) 4 (1990) 149-156